{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:11:56Z","timestamp":1784657516208,"version":"3.55.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Airway bacterial microbiota influences the prognosis in children with respiratory syncytial virus infection. The study aimed to investigate the effect of the airway-dominant bacterial microbiota on disease severity in children with pneumonia of respiratory syncytial virus infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective study was conducted in the Children\u2019s Hospital of Chongqing Medical University, which involved a cohort of patients with respiratory syncytial virus (RSV)-infected pneumonia from January 2012 to December 2021. Patients were assigned to a normal flora group or to a dominant flora group (with the top 5 individual bacteria) based on the nasopharyngeal aspirates culture and matched using propensity-score matching. Univariate analysis and multivariate analysis were performed to estimate the risk factors of poor prognosis in dominant flora.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Five thousand five hundred and twelve patients in the normal flora and 4556 in the dominant flora were included (<jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> 514, <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> 1516, <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> 506, <jats:italic toggle=\"yes\">Moraxella catarrhalis<\/jats:italic> 509 and <jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic> 1516, respectively). The dominant flora had more patients developing severe pneumonia, needing mechanical ventilation\/tracheal intubation (up to 15.8% in the <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>) and admission to the intensive care unit (up to 4.5% in the <jats:italic toggle=\"yes\">E. coli<\/jats:italic>) than in the normal flora (28.5% vs. 25.9%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001; 9.8% vs. 5.4%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; 2.0% vs. 1.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.001). And the hospitalization was longer in the dominant flora than in the normal flora [8 (6\u20139) vs. 8 (7\u20139) days; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001], the <jats:italic toggle=\"yes\">E. coli<\/jats:italic> and <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> had the longest hospitalization [8 (7\u201310) days]. Several factors were associated with critical illness in Dominant flora according to multivariate analysis (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), including age (OR: 0.965; CI: 0.954\u20130.976; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), anhelation (OR: 0.530; CI: 0.446\u20130.631; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), disorders of consciousness (OR: 0.055; CI: 0.016\u20130.185; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) as well as assisted respiration (OR: 0.115; CI: 0.097\u20130.138; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), C-reactive protein &gt;10\u2009mg\/L (OR: 0.686; CI: 0.560\u20130.839; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), SpO<jats:sub>2<\/jats:sub> &lt;90% (OR: 0.366; CI: 0.214\u20130.628; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), pulmonary consolidation (OR: 0.511; CI: 0.364\u20130.717; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and pulmonary atelectasis (OR: 0.362; CI: 0.236\u20130.555; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The airway-dominant bacterial microbiota influenced disease severity and comorbidities in children with RSV-infected pneumonia. Clinicians should pay attention to the nasopharyngeal aspirate culture, especially after detecting <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> and <jats:italic toggle=\"yes\">E. coli<\/jats:italic> in RSV-infected children with pneumonia, closely observe the disease progression and take timely measures to avoid adverse outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004550","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:31:04Z","timestamp":1726752664000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Prognosis in Children With Pneumonia of Respiratory Syncytial Virus Co-detection With Airway Dominant Flora"],"prefix":"10.1097","volume":"44","author":[{"given":"Lu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Data Research Center Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-6974","authenticated-orcid":false,"given":"Enmei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/cix378","article-title":"Microorganisms associated with pneumonia in children <5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case-control study.","volume":"65","author":"B\u00e9net","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1093\/cid\/ciab528","article-title":"Global respiratory syncytial virus-related infant community deaths.","volume":"73","author":"Mazur","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2016.02.025","article-title":"Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review.","volume":"85","author":"Anderson","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants.","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa2106062","article-title":"Prefusion F protein-based respiratory syncytial virus immunization in pregnancy.","volume":"386","author":"Sim\u00f5es","year":"2022","journal-title":"N Engl J Med"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1093\/cid\/ciaa1612","article-title":"Respiratory syncytial virus disease severity in young children.","volume":"73","author":"Haddadin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.prrv.2009.06.003","article-title":"Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes.","volume":"10","author":"Resch","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"e1453","DOI":"10.1542\/peds.2010-0507","article-title":"Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.","volume":"126","author":"Garc\u00eda","year":"2010","journal-title":"Pediatrics"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1093\/infdis\/jiac226","article-title":"Mortality among US infants and children under 5 years of age with respiratory syncytial virus and bronchiolitis: a systematic literature review.","volume":"226","author":"Bylsma","year":"2022","journal-title":"J Infect Dis"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/infdis\/jis721","article-title":"Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.","volume":"207","author":"Mella","year":"2013","journal-title":"J Infect Dis"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"eaaw0268","DOI":"10.1126\/scitranslmed.aaw0268","article-title":"Immune profiles provide insights into respiratory syncytial virus disease severity in young children.","volume":"12","author":"Heinonen","year":"2020","journal-title":"Sci Transl Med"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1164\/rccm.201703-0554OC","article-title":"Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. A prospective cohort study.","volume":"196","author":"Bosch","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","article-title":"The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development.","volume":"17","author":"Teo","year":"2015","journal-title":"Cell Host Microbe"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1164\/rccm.201602-0220OC","article-title":"Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection.","volume":"194","author":"De Steenhuijsen Piters","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/INF.0000000000001500","article-title":"Nasal airway microbiota profile and severe bronchiolitis in infants: a case-control study.","volume":"36","author":"Hasegawa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R17-20250131","first-page":"185","article-title":"Interpretation of the\u300aDiagnostic and Treatment Guidelines for Community-Acquired Pneumonia in Children (2019 Edition)\u300b.","volume":"35","author":"Liu","year":"2020","journal-title":"Chin J Pract Pediatr"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1469-0691.2010.03147.x","article-title":"Impact of bacterial colonization on the severity, and accompanying airway inflammation, of virus-induced wheezing in children.","volume":"16","author":"Yu","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","article-title":"The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis.","volume":"21","author":"Hoeboer","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R20-20250131","first-page":"14","article-title":"Expert consensus on the standardization of reporting of bacterial and fungal smear microscopy and culture results.","volume":"40","author":"Wang","year":"2017","journal-title":"Chin J Lab Med"},{"key":"R21-20250131","first-page":"6","article-title":"Detection of C-reactive protein and ultrasensitive C-reactive protein and their clinical significance.","volume":"5","author":"Zhang","year":"2011","journal-title":"Chin J Allergy Clin Immunol"},{"key":"R24-20250131","first-page":"750","article-title":"Development of a global respiratory severity score for respiratory syncytial virus infection in infants.","volume":"215","author":"Caserta","year":"2017","journal-title":"J Infect Dis"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19.","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R26-20250131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","article-title":"The microbiota of the respiratory tract: gatekeeper to respiratory health.","volume":"15","author":"Man","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"R27-20250131","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/infdis\/jiaa577","article-title":"Temporal dysbiosis of infant nasal microbiota relative to respiratory syncytial virus infection.","volume":"223","author":"Grier","year":"2021","journal-title":"J Infect Dis"},{"key":"R28-20250131","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1164\/rccm.201701-0071OC","article-title":"Associations of nasopharyngeal metabolome and microbiome with severity among infants with bronchiolitis. A multiomic analysis.","volume":"196","author":"Stewart","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R29-20250131","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/pai.13524","article-title":"Respiratory syncytial virus and airway microbiota - A complex interplay and its reflection on morbidity.","volume":"32","author":"Rossi","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"R30-20250131","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1183\/13993003.00152-2016","article-title":"Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.","volume":"48","author":"Hasegawa","year":"2016","journal-title":"Eur Respir J"},{"key":"R31-20250131","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/rccm.201407-1240OC","article-title":"Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children.","volume":"190","author":"Biesbroek","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-20250131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jaci.2017.10.049","article-title":"Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy.","volume":"142","author":"Rosas-Salazar","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R33-20250131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1573396318666220810161945","article-title":"Respiratory syncytial virus is the most common causative agent of viral bronchiolitis in young children: an updated review.","volume":"19","author":"Hon","year":"2023","journal-title":"Curr Pediatr Rev"},{"key":"R34-20250131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/pai.13183","article-title":"Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.","volume":"31","author":"Zhang","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"R35-20250131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-017-0395-y","article-title":"Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.","volume":"6","author":"Ederveen","year":"2018","journal-title":"Microbiome"},{"key":"R36-20250131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.16-0733","article-title":"Severity of pneumonia in under 5-year-old children from developing countries: a multicenter, prospective, observational study.","volume":"97","author":"B\u00e9net","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"R37-20250131","doi-asserted-by":"crossref","first-page":"e00004","DOI":"10.1128\/CVI.00004-17","article-title":"Pneumococcal capsular polysaccharide immunity in the elderly.","volume":"24","author":"Adler","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl S2","key":"R38-20250131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkf506","article-title":"Dynamics of nasopharyngeal colonization by potential respiratory pathogens.","volume":"50","author":"Garc\u00eda-Rodr\u00edguez","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"R40-20250131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/rccm.201311-2110OC","article-title":"Respiratory syncytial virus increases the virulence of streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection.","volume":"190","author":"Smith","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R41-20250131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccm.2021.11.008","article-title":"Diagnosis of primary ciliary dyskinesia.","volume":"43","author":"Goutaki","year":"2022","journal-title":"Clin Chest Med"},{"key":"R42-20250131","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1203\/01.PDR.0000127431.11750.D9","article-title":"Enhanced adherence of streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus.","volume":"55","author":"Hament","year":"2004","journal-title":"Pediatr Res"},{"issue":"Pt 9","key":"R43-20250131","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1099\/0022-1317-68-9-2521","article-title":"Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.","volume":"68 (Pt 9)","author":"Levine","year":"1987","journal-title":"J Gen Virol"},{"key":"R44-20250131","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.00110-14","article-title":"Current and past strategies for bacterial culture in clinical microbiology.","volume":"28","author":"Lagier","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"R45-20250131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOP.0000000000001325","article-title":"Community-acquired bacterial pneumonia in children: an update on antibiotic duration and immunization strategies.","volume":"36","author":"Lyon","year":"2024","journal-title":"Curr Opin Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:01:48Z","timestamp":1738328508000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004550","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}